Characterizing amyloid precursor protein (APP) signaling in neural stem cells.

Alzheimer's disease (AD) is an age-related neurodegenerative disorder that is characterized by irreversible and progressive loss of money and deterioration of higher cognitive functions. The brain of an individual with AD exhibits extracellular senile plaques of aggregated amyloid-beta-peptide...

Full description

Bibliographic Details
Main Author: Heese, Klaus.
Other Authors: School of Biological Sciences
Format: Research Report
Language:English
Published: 2009
Subjects:
Online Access:http://hdl.handle.net/10356/17215
_version_ 1811679567787589632
author Heese, Klaus.
author2 School of Biological Sciences
author_facet School of Biological Sciences
Heese, Klaus.
author_sort Heese, Klaus.
collection NTU
description Alzheimer's disease (AD) is an age-related neurodegenerative disorder that is characterized by irreversible and progressive loss of money and deterioration of higher cognitive functions. The brain of an individual with AD exhibits extracellular senile plaques of aggregated amyloid-beta-peptide AB, intracellular neurofibrilary tangles (NFTs) that contain hyperphosphorylated tau protein (a microtubute associated protein) and a profound loss of basal forebrain cholinergic neurons that innervate the hippocampus and the neocortex. Our observation that the NGF receptor TRKA os downregulated in AD brain led to our suggestion that an imbalance of neurotrophin receptor signalling may be involved in AD. AD appears to have a heterogeneous etiology and can be caused by mutations in the amyloid precursor protein (APP)gene on chromosome-21, the presenilin-1 (PS-1) gene on chromosome-14, and presenilin-2 (PS-2) gene on chromosome-1. Proteolytic processing of APP generates the amyloid-beta peptide (AB) and has been implicated in the pathogenesis of AD. APP fragments, including AB and APP's C-termial fragments (CTFs) or APP's intracellular domains (AICDs), have been reported to cause apoptosis. Mutations in the APP encoding gene and also in PS-1/2, which lead to early-onset AD, are associated with excess AB deposition in the brains of AD patient suggesting that the depositon of AB is a central disease-causing evant. However, the physiological function of APP and whether this function is related to the proteolytic processing of APP remains unclear. Moreover, the mechanism for the degeneration of nerve cells and synaptic connections that underlies the emergence of dementia, in particular in sporadic AD, is still unknown[1,2]
first_indexed 2024-10-01T03:11:13Z
format Research Report
id ntu-10356/17215
institution Nanyang Technological University
language English
last_indexed 2024-10-01T03:11:13Z
publishDate 2009
record_format dspace
spelling ntu-10356/172152023-02-28T17:58:13Z Characterizing amyloid precursor protein (APP) signaling in neural stem cells. Heese, Klaus. School of Biological Sciences DRNTU::Science::Biological sciences::Human anatomy and physiology::Neurobiology Alzheimer's disease (AD) is an age-related neurodegenerative disorder that is characterized by irreversible and progressive loss of money and deterioration of higher cognitive functions. The brain of an individual with AD exhibits extracellular senile plaques of aggregated amyloid-beta-peptide AB, intracellular neurofibrilary tangles (NFTs) that contain hyperphosphorylated tau protein (a microtubute associated protein) and a profound loss of basal forebrain cholinergic neurons that innervate the hippocampus and the neocortex. Our observation that the NGF receptor TRKA os downregulated in AD brain led to our suggestion that an imbalance of neurotrophin receptor signalling may be involved in AD. AD appears to have a heterogeneous etiology and can be caused by mutations in the amyloid precursor protein (APP)gene on chromosome-21, the presenilin-1 (PS-1) gene on chromosome-14, and presenilin-2 (PS-2) gene on chromosome-1. Proteolytic processing of APP generates the amyloid-beta peptide (AB) and has been implicated in the pathogenesis of AD. APP fragments, including AB and APP's C-termial fragments (CTFs) or APP's intracellular domains (AICDs), have been reported to cause apoptosis. Mutations in the APP encoding gene and also in PS-1/2, which lead to early-onset AD, are associated with excess AB deposition in the brains of AD patient suggesting that the depositon of AB is a central disease-causing evant. However, the physiological function of APP and whether this function is related to the proteolytic processing of APP remains unclear. Moreover, the mechanism for the degeneration of nerve cells and synaptic connections that underlies the emergence of dementia, in particular in sporadic AD, is still unknown[1,2] RG 147/06 2009-06-01T08:32:53Z 2009-06-01T08:32:53Z 2008 2008 Research Report http://hdl.handle.net/10356/17215 en 16 p. application/pdf
spellingShingle DRNTU::Science::Biological sciences::Human anatomy and physiology::Neurobiology
Heese, Klaus.
Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title_full Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title_fullStr Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title_full_unstemmed Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title_short Characterizing amyloid precursor protein (APP) signaling in neural stem cells.
title_sort characterizing amyloid precursor protein app signaling in neural stem cells
topic DRNTU::Science::Biological sciences::Human anatomy and physiology::Neurobiology
url http://hdl.handle.net/10356/17215
work_keys_str_mv AT heeseklaus characterizingamyloidprecursorproteinappsignalinginneuralstemcells